CA-A Cancer Journal for Clinicians

Papers
(The H4-Index of CA-A Cancer Journal for Clinicians is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries63474
Cancer Statistics, 202112375
Cancer statistics, 202211692
Cancer statistics, 20238177
Cancer statistics, 20241391
Cancer treatment and survivorship statistics, 20221332
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries1263
Breast Cancer Statistics, 2022987
Colorectal cancer statistics, 2023950
Current treatment and recent progress in gastric cancer922
Brain and other central nervous system tumor statistics, 2021512
Metabolomics in cancer research and emerging applications in clinical oncology351
American Cancer Society nutrition and physical activity guideline for cancer survivors322
Cancer statistics for African American/Black People 2022310
Clinical management of metastatic colorectal cancer in the era of precision medicine238
Cancer statistics for the US Hispanic/Latino population, 2021227
Integrative oncology: Addressing the global challenges of cancer prevention and treatment187
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies183
Radiation therapy‐associated toxicity: Etiology, management, and prevention175
167
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians159
Molecular imaging in oncology: Current impact and future directions149
American Cancer Society's report on the status of cancer disparities in the United States, 2021137
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions113
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach107
Cervical cancer prevention and control in women living with human immunodeficiency virus97
The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies89
88
Cancer epigenetics in clinical practice87
The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer86
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward85
Intermittent fasting in the prevention and treatment of cancer85
79
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review72
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions71
68
Cancer statistics forAmericanIndian andAlaskaNative individuals, 2022: Including increasing disparities in early onset colorectal cancer65
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature64
Blueprint for cancer research: Critical gaps and opportunities62
Recent progress in the treatment of cancer in children61
The contemporary management of cancers of the sinonasal tract in adults60
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians53
An overview of real‐world data sources for oncology and considerations for research51
Screening for lung cancer: 2023 guideline update from the American Cancer Society51
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer47
Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children's Oncology Group Adolescent and Young Adult Oncology Discipline Committee46
0.029755115509033